Group receiving research intervention.
1No local or systemic adverse effects were seen from either treatment group.
2Statistical analysis: Data were analyzed as mean values for each treatment group.
3Regression rates were similar by treatment group in patients with low VEGF.
4This is explained by a higher restenosis rate in this treatment group.
5Two patients died during the study period, 1 in each treatment group.
6At baseline, there were no significant treatment group differences in OT levels.
7The control pups of the first treatment group were untreated litter mates.
8The incidence of reperfusion-induced arrhythmias was significantly lower in the treatment group.
9All participants, investigators, and the sponsor were masked to treatment group assignment.
10Results: A total of 473 employees in each treatment group were identified.
11Results: No significant safety issues were observed in any treatment group.
12Parents also reported improved sports skills and good sportsmanship in the treatment group.
13Symptomatic improvement was seen in at least 10 patients in each treatment group.
14During the first month of treatment , ALT levels declined gradually in treatment group.
15There were few severe adverse events or laboratory abnormalities in either treatment group.
16Responsiveness to change was calculated for all patients and in each treatment group.